Chromadex Corp [CDXC] stock prices are up 5.13% to $5.94 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CDXC shares have gain 12.71% over the last week, with a monthly amount drifted -3.41%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Chromadex Corp [NASDAQ: CDXC] stock has seen the most recent analyst activity on August 16, 2022, when Oppenheimer downgraded its rating to a Perform. Previously, B. Riley Securities downgraded its rating to Neutral on August 11, 2022, and dropped its price target to $2.40. On March 08, 2022, ROTH Capital initiated with a Buy rating and assigned a price target of $7 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $6 on October 16, 2019. B. Riley FBR initiated its recommendation with a Buy and recommended $7 as its price target on February 14, 2019. In a note dated September 25, 2017, Ladenburg Thalmann initiated an Buy rating and provided a target price of $7 on this stock.
The stock price of Chromadex Corp [CDXC] has been fluctuating between $1.36 and $7.97 over the past year. Chromadex Corp [NASDAQ: CDXC] shares were valued at $5.94 at the most recent close of the market.
Analyzing the CDXC fundamentals
The Chromadex Corp [NASDAQ:CDXC] reported sales of 91.67M for trailing twelve months, representing a surge of 31.21%. Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.72 points at the first support level, and at 5.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.10, and for the 2nd resistance point, it is at 6.25.
Ratios To Look Out For
It’s worth pointing out that Chromadex Corp [NASDAQ:CDXC]’s Current Ratio is 2.95. Also, the Quick Ratio is 2.35, while the Cash Ratio stands at 1.83. Considering the valuation of this stock, the price to sales ratio is 4.95, the price to book ratio is 13.14 and price to earnings (TTM) ratio is 314.29.
Transactions by insiders
Recent insider trading involved Jaksch Frank L Jr, Director, that happened on Dec 13 ’24 when 37161.0 shares were sold. affiliate, Frank Jaksch Jr. completed a deal on Dec 13 ’24 to buy 37161.0 shares. Meanwhile, Chief Financial Officer Pamir Ozan bought 2907.0 shares on Nov 22 ’24.
